Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients. [electronic resource]
Producer: 20070112Description: 23-33 p. digitalISSN:- 0344-5704
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Area Under Curve
- Camptothecin -- administration & dosage
- Celecoxib
- Chemotherapy, Adjuvant
- Chromatography, High Pressure Liquid
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Fibroblast Growth Factor 2 -- metabolism
- Follow-Up Studies
- Humans
- Irinotecan
- Male
- Middle Aged
- NF-kappa B -- antagonists & inhibitors
- Neoplasms -- drug therapy
- Pyrazoles -- administration & dosage
- Sulfonamides -- administration & dosage
- Thalidomide -- administration & dosage
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.